Monoclonal antibody pair of main allergen Der p1 of dermatophagoides pteronyssinus, hybridoma cell and application

The specific antibodies DP1.10 and DF1.7 were screened out through semi-solid culture technology, which solved the problem of cross-reacting of the main allergen of house dust mites Der p 1 and the main allergen of dust mites Der f 1, and realized the problem of the cross-reacting house dust mites High sensitivity and specific detection of the main allergen Der p 1.

CN118879641APending Publication Date: 2024-11-01PEKING UNION MEDICAL COLLEGE HOSPITAL
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410986180.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

The existing monoclonal antibody of the house dust mite main allergen Der p 1 has a cross-reaction with the dust mite main allergen Der f 1, which affects the detection specificity and is difficult to effectively identify and quantify the main allergen of the house dust mite Der p 1 .

Method used

Using semi-solid culture technology, the spleen cells of BALB/c mice immunized with BALB/c mice were fused with SP2/0 myeloma cells to screen for hybridoma cell lines that specifically secrete anti-Der p1 protein monoclonal antibodies. , antibodies DP1.10 and DF1.7 that do not cross-react with Der f1 were prepared, and were used to establish an immunological detection method for the main allergen of Der p1 in the house dust mite.

Benefits of technology

The obtained antibody pair can recognize and bind Der p1 protein with high sensitivity and specific sensitivity. It is used in ELISA experimental technology, achieving rapid and accurate detection of the main allergen of Der p1 in the house dust mite, avoiding the Der p1 with Der p1. The cross-reaction improves the specificity and accuracy of the detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004957461980000091
    Figure BDA0004957461980000091
  • Figure BDA0004957461980000121
    Figure BDA0004957461980000121
  • Figure BDA0004957461980000132
    Figure BDA0004957461980000132
Patent Text Reader

Abstract

The invention relates to a house dust mite main allergen Der p1 monoclonal antibody pair, a hybridoma cell and application, and particularly provides a pair of monoclonal antibodies for detecting house dust mite main allergen Der p1, a hybridoma cell strain secreting the antibody pair and application. The invention provides a hybridoma cell for preparing a monoclonal antibody of a main allergen Der p1 of dermatophagoides pteronyssinus, and the preservation number of the hybridoma cell is CGMCC (China General Microbiological Culture Collection Center) No.45843, CGMCC No.45844. The two hybridoma cells are used for preparing the anti-Der p 1 monoclonal antibody pair, the anti-Der p 1 monoclonal antibody pair can specifically recognize and combine with Der p 1 protein, specificity is high, sensitivity is high, and the obtained monoclonal antibody has high detection sensitivity when being used for detecting dermatophagoides pteronyssinus allergen Der p 1.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field, and in particular relates to a pair of monoclonal antibodies to a main allergen Der p1 of a house dust mite, a hybridoma cell and an application thereof. Background Art

[0002] House dust mite (Dermatophagoides pteronyssinus) is the main allergen that causes allergic diseases. Among them, the main allergen Der p 1, which exists in the intestinal contents and midgut tissues of mites, is a cysteine ​​protease with a molecular weight of 25,000 and belongs to the papain family. At present, about 95% of the serum of patients allergic to house dust mites reacts with Der p 1.

[0003] It may induce allergic reactions by cutting off the IL-2 receptor on the surface of peripheral blood T cells through cysteine ​​protease activity, inhibiting T cell proliferation and IFN-γ secretion, or by cutting off CD23 on the surface of B cells, eliminating the inhibitory signal of IgE synthesis and stimulating the production pathway of IgE.

[0004] At present, standardized house dust mite allergens are often used in clinical practice to specifically diagnose house dust mite allergies and perform desensitization treatment. As the main allergen of house dust mites, the content of Der p1 in desensitization drugs has become an important indicator for evaluating the effectiveness of drugs. Therefore, the preparation of a monoclonal antibody that can detect Der P1 antigen is of great significance for the quality control of allergen extracts and the standardization and mutual comparison of allergen products.

[0005] Several anti-Der p 1 monoclonal antibodies are currently on the market, but they all have varying degrees of cross-reactivity with the main allergen of dust mites, Der f 1, which affects the specificity of detection. Der p 1 and Der f 1 belong to the papain family of cysteine ​​proteases, and their amino acid sequences have 82% sequence similarity. However, their amino acid residues are unevenly distributed on the surface of the protein spatial structure, and their allergen epitopes do not completely overlap.

[0006] The invention uses semi-solid culture technology to successfully prepare a specific anti-Der p 1 monoclonal antibody that does not cross-react with Der f 1. Summary of the invention

[0007] The present invention aims to provide a hybridoma cell for preparing a monoclonal antibody against Der p 1, a major allergen of house dust mites. The antibody prepared by the cell line has good specificity and detection sensitivity for Der p 1, a major allergen of house dust mites, and can be used to establish an immunological detection method for Der p 1, a major allergen of house dust mites.

[0008] Another object of the present invention is to provide an antibody pair for detecting the content of Der p 1, a major allergen of house dust mites, and the use of the antibody pair in quantitative detection of allergen products.

[0009] To achieve the above object, the present invention adopts the following technical solutions:

[0010] The hybridoma cells used to prepare monoclonal antibodies against Der p 1, the major allergen of house dust mites, were deposited in the General Microbiology Center of China National Microbiological Culture Collection Administration on April 17, 2024, and their deposit numbers are: CGMCC No.45843 and CGMCC No.45844.

[0011] The invention utilizes purified natural Der p 1 protein to immunize BALB / c mice, obtains spleen cells of the immunized mice and fuses them with SP2 / 0 myeloma cells, screens hybridoma cells on a methylcellulose semisolid culture medium, and uses an Elisa method to screen positive hybridoma cells to obtain a hybridoma cell line that specifically secretes anti-Der p 1 protein monoclonal antibodies.

[0012] The antibody pair used for detecting the content of Der p 1, a major allergen of house dust mites, is prepared by intraperitoneally injecting the hybridoma cells obtained above into parous BALB / c female mice, collecting ascites, purifying monoclonal antibodies, and obtaining anti-Der p 1 monoclonal antibodies DP1.10 and DF1.7.

[0013] Use of the antibody pair for detecting the content of the major allergen Der p 1 of house dust mites as described above in the preparation of a preparation for detecting the major Der p 1 antigen of house dust mites.

[0014] A detection kit for detecting the main Der p1 antigen of house dust mites comprises a monoclonal antibody prepared by mouse hybridoma cells with a deposit number of CGMCC No. 45843 as a capture antibody, and a monoclonal antibody labeled with HRP prepared by mouse hybridoma cells with a deposit number of CGMCC No. 45844 as a detection antibody.

[0015] A method for detecting the main allergen Der p 1 of house dust mites comprises the following steps:

[0016] S1. The antibody prepared by hybridoma cell CGMCC No.45844 is used as capture antibody to coat the ELISA coated plate;

[0017] S2, after washing, block with blocking solution and then wash;

[0018] S3, adding the test solution to the ELISA coated plate, incubating, and washing;

[0019] S4, adding HRP-conjugated antibodies prepared by hybridoma cell CGMCC No.45845, incubating, and then washing;

[0020] S5. After adding TMB, the reaction was terminated by adding stop solution and the absorbance at a wavelength of 450 nm was detected by an ELISA reader.

[0021] In the above method, preferably, standard samples with different Der p 1 protein concentrations are prepared at the same time. After detection according to the above method, a dose-response standard curve is drawn, and then the absorbance value of the test solution is substituted into the standard curve to obtain the concentration of Der p 1 protein in the test solution.

[0022] The beneficial effects of the present invention are:

[0023] The hybridoma cell for preparing monoclonal antibody against Der p 1, a major allergen of house dust mites, provided by the present invention can prepare monoclonal antibody against Der p 1, which can specifically recognize and bind to Der p 1 protein, has high specificity and strong sensitivity. Under the same conditions, the monoclonal antibody against Der p 1 provided by the present invention can be used in ELISA experimental technology to detect Der p 1, a major allergen of house dust mites, with high sensitivity and rapidity. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 Schematic diagram of the dose-response standard curve.

[0025] Figure 2 is the absorbance value detected by specific reaction. DETAILED DESCRIPTION

[0026] The following examples are used to further illustrate the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and substance of the present invention, modifications or substitutions made to the present invention all belong to the scope of the present invention.

[0027] Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art. Unless otherwise specified, the reagents used in the present invention are of analytical grade or above.

[0028] Example 1 Immunization of BLAB / c mice

[0029] (I) Preparation of Antigen

[0030] Take 40 g of house dust mite raw material (purchased from Beijing Xinhualian Xiehe Pharmaceutical Co., Ltd.), add 800 ml of NH4HCO3, and extract overnight at 4°C. Centrifuge twice at 12,000 g for 15 min, take the supernatant, filter with filter paper and 0.22 μm filter. After filtration, it is about 600 ml. Slowly add 234 g of (NH4)2SO4 and let it stand overnight at 4°C. Centrifuge twice at 12,000 g for 15 min, keep the supernatant, and dissolve the precipitate with 0.05 M Tris-HCl, pH 8.0 (about 37 ml). Dialyze overnight with 0.05 M Tris-HCl, pH 8.0. After dialysis, filter through a 0.22 μm PVDF membrane and use a DEAE DEAE-cellulose anion exchange column: column equilibration (0.05 M Tris-HCl, PH 8.0), elute with 500 ml of 0.05 M Tris-HCL solution containing 0.3 M NaCl, pH 7.4. Under this condition, the acidic protein Der p 1 (PI < PH, negatively charged) is eluted during the elution stage. Ultrafiltrate and concentrate to 40 ml, and dialyze into a buffer of 0.05 M sodium borate containing 2 M sodium chloride, pH 8.0. Continue to purify using a Phenyl column (equilibrate with 0.05 M sodium borate containing 2 M sodium chloride, pH 8.0, and then elute with 0.05 M sodium borate solution containing 50% ethylene glycol, pH 8.0). Collect the eluate, ultrafiltrate and concentrate to 20 ml, then purify using a Superdex 75 column, collect the target peak, and ultrafiltrate and concentrate to 5 ml. Dialyze into 0.05 M Tris-acetate buffer (containing 0.5 M sodium chloride, pH 7.5), and then purify using a Zinc column (equilibrate with 0.05 M Tris-acetate buffer, pH 7.5, and elute with a gradient decrease of 0.05 M Tris-acetate buffer, pH 7.5 - 5.0, collect the peak eluted in the range of pH 5.7 - 5.2). Finally, obtain the purified Der p 1 protein. Dialyze it into PBS for storage.

[0031] (II) Immunization of Mice

[0032] Take 5 healthy 6-week-old female BALB / c mice (purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd.). Thoroughly mix 30 μg of purified Der p 1 protein (per mouse) with an equal volume of Freund's complete adjuvant and inject subcutaneously at multiple points on the abdomen. The time interval between each immunization is two weeks after the first immunization. After the fifth immunization, collect blood from the orbital vein one week later, collect the serum, and use the indirect ELISA method to determine the serum titer of the mice to evaluate the immune effect. If the serum titer is qualified, strengthen the immunization by injecting 35 μg of Der p 1 protein (per mouse) once through the tail vein three days before fusion.

[0033] Example 2 Preparation of anti-Der p 1 monoclonal antibody

[0034] (I) Preparation of myeloma cells

[0035] One week before fusion, SP2 / 0 myeloma cells (purchased from the Cell Resource Center of the Institute of Basic Medicine, Chinese Academy of Medical Sciences) were revived and expanded to ensure that the cells were in the logarithmic growth phase and in the best condition at the time of fusion; on the day of fusion, the cells were gently blown off with a pipette, collected in a 50 mL centrifuge tube, centrifuged at 300 g for 5 min, the supernatant was discarded, and the cells were resuspended in IMDM medium and counted for later use.

[0036] (II) Preparation of feeder cells

[0037] Prepare feeder cells on the day of fusion as follows:

[0038] 1. Take a healthy female BALB / c mouse of 3 weeks old, remove the eyeball of the mouse and bleed it, and disinfect the body surface with 75% ethanol;

[0039] 2. Place the mouse on the operating table with the abdomen facing upwards; cut the chest cavity below the sternum of the mouse, and the white transparent thymus can be seen;

[0040] 3. Remove the thymus and soak it in IMDM medium;

[0041] 4. Place the thymus in a 200-mesh sieve and grind it gently with a tissue grinder until there are no obvious lumps;

[0042] 5. Rinse the sieve with 10 mL of IMDM medium and collect the rinse solution in a 15 mL centrifuge tube. Centrifuge at 300 g for 5 min and discard the supernatant.

[0043] 6. Resuspend the thymocytes in 10 ml of fetal bovine serum.

[0044] (III) Preparation of spleen cells from immunized mice

[0045] Prepare mouse spleen cells on the day of fusion as follows:

[0046] 1. Take one mouse immunized in Example 1, remove its eyeballs and bleed it, and use 75% ethanol to disinfect the body surface;

[0047] 2. Place the mouse on the operating table with the left ventral side facing up; cut the skin in the middle of the left ventral side of the mouse, separate the skin and peritoneum, fully expose the abdominal wall, and the red long spleen can be seen;

[0048] 3. Lift the peritoneum on the lower side of the spleen, cut it open and flip it up to expose the spleen. Lift the spleen with forceps, separate the connective tissue under the spleen with scissors, and take out the spleen; put it into a sterile EP tube containing 5 ml IMDM culture medium;

[0049] 4. Place the spleen in a 200-mesh sieve and grind it gently with a tissue grinder until there are no obvious lumps;

[0050] 5. Rinse the sieve with 10 mL of IMDM medium and collect the rinse solution in a 15 mL centrifuge tube. Centrifuge at 300 g for 5 min and discard the supernatant.

[0051] 6. Resuspend mouse spleen cells in IMDM.

[0052] (IV) Cell fusion

[0053] 1. Take 1×10 8 splenocytes of immunized mice and 1×10 7 Add SP2 / 0 myeloma cells to a 50 mL centrifuge tube, add IMDM to a final volume of 10 ml, and centrifuge at 300 g for 5 min;

[0054] 2. Discard the supernatant and remove the remaining liquid as much as possible. Tap the bottom of the fusion tube lightly with your palm to loosen and evenly distribute the precipitated cells.

[0055] 3. Place the centrifuge tube in 37℃ sterile water, slowly add 1ml of 50% PEG 1500 fusion agent into the centrifuge tube, add it within about 1 minute, and let it stand for 1 minute;

[0056] 4. Slowly add 2 ml of IMDM medium along the wall of the centrifuge tube for about 2 minutes.

[0057] 5. Then slowly add 8 ml of IMDM medium within 2 minutes to terminate the effect of PEG 1500 fusion agent;

[0058] 6. Centrifuge the fused cells at 300g for 5 minutes, discard the supernatant, mix the precipitate with thymocytes, add 2 ml of HAT selection medium, and add IMDM medium to make the final volume 15 ml.

[0059] 7. Pour 25 ml of 2% methylcellulose IMDM semi-solid culture medium and mix thoroughly. Inoculate into a sterile plastic dish with a diameter of 35 mm, 2 ml / dish. Place the plastic dish in a humidified box and culture it in a 37°C, 5% CO2 incubator.

[0060] (V) Clonal transfer

[0061] On the sixth day after fusion, a healthy female BALB / c mouse aged 3 weeks was taken and feeder cells were prepared according to step (II) 1-5. An appropriate amount of DMEM medium containing 20% ​​fetal bovine serum was added to the precipitate to make the cell density 10 5 Under a dissecting microscope, use a pipette to transfer the clones in the dish to a 96-well plate for further culture.

[0062] (VI) Screening of hybridoma cells

[0063] Two days after clone transfer, positive clones were screened by indirect enzyme-linked immunosorbent assay.

[0064] The purified Der p 1 protein obtained in Example 1 was diluted to 25ug / mL with coating solution (0.05M Tris-HCl), and 100μL was coated in each well at 4℃ overnight; blocked at room temperature for 2h; 100μL of cell culture supernatant was added to each well and incubated at 37℃ for 30min; after washing, enzyme-labeled secondary antibody (1:5000) was added, 100μL / well, and incubated at 37℃ for 30min; after washing, substrate solution (TMB) was added, 100uL / well, and color was developed in the dark for 10min; 50uL 2M H2SO4 was added to each well to terminate the reaction and observe the results. The positive clones screened out were retested the next day, and the recombinant His-alt a 1 protein was used as an antigen to exclude clones targeting the His tag. Six positive clones were screened out, and the labeled numbers were DP1.1, DP1.6, DP1.10, DP1.11, DP1.77, and DF1.7, respectively. The positive clones screened were amplified and stored in liquid nitrogen.

[0065] (VII) Large-scale preparation of monoclonal antibodies

[0066] Ascites was prepared using the in vivo ascites induction method. The specific steps are as follows:

[0067] 1. Select multiparous female BLAB / c mice and intraperitoneally inject 0.5 mL of sterilized liquid paraffin oil per mouse;

[0068] 2. Resuscitate the above-mentioned 6 frozen positive clones of hybridoma cells and continue to culture. Select hybridoma cells in the logarithmic growth phase, gently blow them off, centrifuge at 300g for 5 minutes, discard the supernatant, resuspend them with DMEM, count and set aside;

[0069] 3. Each mouse was intraperitoneally injected with 5×10 5 -1×10 6 hybridoma cells;

[0070] 4. After 7-10 days, the abdomen of the mouse will be significantly enlarged, and ascites will be collected;

[0071] 5. Centrifuge the mouse ascites at 3000 rpm for 10 min, collect the supernatant, and store it at -20°C for later use.

[0072] (VIII) Purification of Ascites

[0073] 1. Dilute the ascites with 4 volumes of acetate buffer (60 mM pH 4.0, pH 4.5);

[0074] 2. Add 25 μl of octanoic acid per ml of diluted sample, stirring for 30 min, and centrifuge at 10,000 g at 16°C for 30 min.

[0075] 3. Filter the supernatant with filter paper to remove fine residues, add 10-fold concentrated PBS (9 samples plus 1 part PBS), and adjust the pH to 7.4 with 5M NaOH;

[0076] 4. Cool the supernatant to 4°C, add 45% saturated ammonium sulfate to precipitate the supernatant (0.277 g / ml), and let stand at 4°C for 30 min;

[0077] 5. Centrifuge at 10,000 g for 10 min at 4°C, take a small amount of PBS to resuspend the precipitate, dialyze against PBS at 4°C overnight to obtain 6 purified antibody solutions (the corresponding antibodies are denoted as antibodies DP1.1, DP1.6, DP1.10, DP1.11, DP1.77, and DF1.7).

[0078] Example 3 Identification and pairing of anti-Der p 1 monoclonal antibodies

[0079] (I) Pairing test

[0080] Take 5 mg of horseradish peroxidase (HRP), dissolve it in 0.5 mL of 0.2 M sodium acetate buffer (pH 5.6), mix it with 0.25 mL of 0.1 M sodium periodate solution, and place it at 4 ° C for 30 min. Add 0.5 mL of 2.5% ethylene glycol solution, mix it and place it in a 4 ° C refrigerator for 30 min. Take the purified antibody obtained in Example 2 and prepare it into 5 mg / mL 1 mL, adjust the pH to 9.0 with 1 M sodium carbonate buffer (pH 9.5). Mix the purified antibody solution and HRP solution, adjust the pH to 9.0 with 1 M sodium carbonate buffer (pH 9.5), and place it in a 4 ° C refrigerator overnight. Add 0.1 mL of 0.1 M sodium borohydride solution, place it at 4 ° C for 2 hours to terminate the reaction, and obtain HRP-bound antibody. Add the HRP-bound antibody to a dialysis bag, place it in 0.01 M PBS solution (pH 7.4), and dialyze it at 4 ° C overnight. Collect HRP-conjugated antibodies, add 0.5% BSA and store in a 4°C refrigerator. Use the double antibody sandwich method to pair antibodies, unlabeled purified antibodies as capture antibodies, HRP-conjugated antibodies as binding antibodies, and screen a series of paired antibody pairs. The specific experimental operation is as follows:

[0081] 1. Take capture antibodies (DP1.1, DP1.6, DP1.10, DP1.11, DP1.77, DF1.7) and add coating buffer (0.05M Tris-HCl) to a final concentration of 3.5μg / mL. Add 100uL to each well and incubate at 4℃ overnight.

[0082] 2. Discard the solution and add 300 μL TBST to each well and wash three times.

[0083] 3. Add 200 μL of blocking solution (0.5% BSA by mass) to each well and leave at room temperature for 2 hours.

[0084] 4. Discard the blocking solution and make a Der p 1 capture coated plate after drying.

[0085] 5. Take 100 ng / mL of Der p 1 antigen, 100 μL / well, and add it into the wells of the coated plate configured above;

[0086] 6. Cover with sealing film and incubate at 37°C for 30 minutes;

[0087] 7. Take out, wash the plate 3 times with washing solution (TBST), and pat dry;

[0088] 8. Dilute the HRP-conjugated antibody prepared above with 1:1000 blocking solution, 100 μL / well, and add to the wells of the coated plate prepared above;

[0089] 9. Cover with sealing film and incubate at 37°C for 30 minutes;

[0090] 10. Take out, wash the plate 3 times with washing solution (TBST), and pat dry;

[0091] 11. Add 100 μL TMB to each well and react for 10 minutes;

[0092] 12. Add 50 μL of stop solution (2M H2SO4) to each well to terminate the reaction;

[0093] 13. Use an enzyme-labeled instrument to detect the absorbance value at a wavelength of 450 nm. The results are shown in Table 1.

[0094] Table 1 ELISA detection absorbance values

[0095]

[0096] The results showed that the absorbance value of the antibody DF1.7-DP1.10 HRP group was the highest, indicating that the ability of these two strains of antibodies to specifically bind to the Der p 1 antigen was the strongest. This pair of antibodies was selected for antibody type identification, titer determination and cross-reactivity determination.

[0097] The obtained hybridoma cells DP1.10 and DF1.7 were sent to the General Microbiology Center of China Culture Collection Administration (address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code: 100101) for patent preservation on April 17, 2024, and their preservation numbers are: CGMCC No.45843 and CGMCC No.45844, respectively, and they are classified and named as mouse hybridoma cells.

[0098] (II) Identification of antibody types

[0099] Agar was prepared into 100 mL of 2% agarose solution with barbiturate buffer at pH 6.0 and boiled in water. When the temperature of the molten agar was about 50°C, 0.01 g of sodium azide was added and 16 mL of agarose solution was transferred to a transparent pre-coated glass plate (10×8.5 cm) to make an agar plate. After the agar solidified, a central hole and six peripheral holes were punched in the agar, and the agar in the holes was removed with a needle. The antibodies p1.10 and f1.7 prepared by the present invention were placed in the central hole, and IgG1, IgG2a, and IgG2b (purchased from Southern Biotech) solutions were placed in the peripheral holes. The agar plate with the sample added was placed in a wet box and placed in a 37°C incubator for 24 hours to observe the results. The precipitation line formed between the central hole and the IgG1 hole indicated that the antibody DP1.10 and DF1.7 cell line subtype prepared by the present invention was IgG1.

[0100] (III) Determination of antibody titer

[0101] Coat the purified Der p 1 protein, 25 μg per plate, overnight at 4°C; block at room temperature for 2 hours; dilute the purified monoclonal antibody (8 mg / mL) with blocking solution (0.5% BSA) (starting from 1:500 dilution), 100 μL / well, and add blank (PBST) or negative control solution, incubate at 37°C for 30 minutes; after washing, add goat anti-mouse enzyme-labeled secondary antibody (1:5000), 100 μL / well, incubate at 37°C for 30 minutes; after washing, add substrate solution (TMB), 100 μL / well, color development in the dark for 10 minutes; add 50 μL 2MH2SO4 to each well to terminate the reaction, and measure the OD450 value of each well with an enzyme-labeled instrument. If the OD value of the well to be tested is greater than 0.1 and greater than 2.1 times that of the negative control well, it is judged as positive, and the highest dilution multiple judged as positive is the antibody titer. The monoclonal antibodies DP1.10 and DF1.7 prepared by the present invention have a titer of 1:10 7 .

[0102] It is shown that the mouse hybridoma cells DP1.10 and DF1.7 obtained in the present invention can be used to prepare monoclonal antibodies against major allergens of house dust mites, and can be used to prepare reagents for detecting Der p 1 protein or house dust mites.

[0103] Example 4 Application of Antibody Pairs in ELISA Kits

[0104] According to the existing chemiluminescence diagnostic reagent production process, the DF1.7 antibody obtained in Example 2 was used as a capture antibody to be coated and configured into a Der p 1 coated plate, the antibody labeled HRP obtained in Example 3, namely DP1.10-HRP, was used as a binding antibody to be configured into an enzyme conjugate of the Der p 1 antibody, and the Der p 1 antigen was configured into a series of calibrators (1 ng / ml, 2 ng / ml, 4 ng / ml, 8 ng / ml, 16 ng / ml, 32 ng / ml, 64 ng / ml) to form a complete kit, and a series of verifications were performed on it.

[0105] (I) Performance verification indicators

[0106] Refer to the technical requirements of existing Der p 1 detection kits on the market and formulate performance verification indicators for detection reagents.

[0107] 1. Linearity of dose-response curve

[0108] In the linear range of 1ng / ml-64ng / ml, the linear correlation coefficient (r) of the dose-response curve should be no less than 0.9900.

[0109] 2. Detection limit

[0110] Should not be higher than 1ng / ml.

[0111] 3. Limit of Quantitation

[0112] Should not be higher than 2ng / ml.

[0113] 4. Specificity

[0114] The established method was used to detect the concentrations of gradient diluted antigens Der p 1, Der p 2, Der f 1, and Der f 2 to verify the specificity of the method.

[0115] 5. Accuracy

[0116] The spike recovery rate was tested with a test kit and the spike recovery rate result should be within the range of 85%-115%.

[0117] 6. Precision

[0118] The precision (CV) should not be greater than 15%.

[0119] (II) Experimental configuration

[0120] 1. Der p 1 capture antibody coated plate configuration

[0121] Use antibody DF 1.7 as capture antibody, add coating buffer (0.05M Tris-HCl), and the final concentration of capture antibody coating is 3.8μg / mL. Add 100μl to each well and incubate at 4℃ overnight. Take out and wash 3 times with 300μL TBST per well. Add 200μl blocking solution (0.5% BSA) to each well and leave at room temperature for 2h. Discard the blocking solution and make Der p 1 capture antibody coated plate after drying.

[0122] 2. Der p 1 enzyme conjugate configuration

[0123] The DP1.10-HRP conjugated antibody obtained in Example 3 was added to the enzyme diluent (0.1 M Tris + 0.5% BSA) at a ratio of 1:2000.

[0124] 3. Calibration product configuration

[0125] The Der p 1 antigen was diluted with an antigen diluent (0.5% BSA-PBS) into seven gradients (1 ng / ml, 2 ng / ml, 4 ng / ml, 8 ng / ml, 16 ng / ml, 32 ng / ml, 64 ng / ml).

[0126] 4. Recovery rate standard solution configuration

[0127] The Der p 1 antigen was diluted with antigen diluent (0.5% BSA-PBS) as the standard solution, and 1.38 ng / mL dust mite extract (purchased from Beijing Union New Hualian Pharmaceutical Co., Ltd.) was selected as the low value sample.

[0128] 5. Quality control product configuration

[0129] Der p 1 antigen was diluted with antigen diluent (0.5% BSA-PBS) to obtain QC1 (2 ng / ml±10%), QC2 (7 ng / ml±10%), and QC3 (20 ng / ml±10%).

[0130] (III) Sample addition operation

[0131] 1. Take 50 μl of the above-prepared calibrator, recovery standard solution and quality control product respectively and add them into the wells of the above-prepared coated plate, then take 50 μl of the above-prepared DP1.10-HRP conjugated antibody and add it into the wells of the above-prepared coated plate, and shake on an oscillator for 30 seconds to mix them thoroughly;

[0132] 2. Cover with sealing film and incubate at 37℃ for 30 minutes;

[0133] 3. Take out and wash the plate 3 times with washing solution (TBST);

[0134] 4. Add 100 μl TMB to each well and react for 5 minutes;

[0135] 5. Add 50 μl of stop solution (2M H2SO4) to each well to terminate the reaction;

[0136] 6. Use an enzyme-labeled instrument to detect the absorbance value at a wavelength of 450 nm.

[0137] (IV) Performance Index Assessment

[0138] 1. Linearity of dose-response curve

[0139] The calibrators of the kit were measured in duplicate (the concentrations were 1 ng / ml, 2 ng / ml, 4 ng / ml, 8 ng / ml, 16 ng / ml, 32 ng / ml, and 64 ng / ml, respectively). The measurements were repeated three times, and the dose-response curve of the kit was fitted using the four-parameter method. The dose-response curve is shown in Figure 1 shown.

[0140] Depend on Figure 1 It can be seen that the linear correlation coefficient R of the Der p 1 antigen curve in the concentration range of 1-64ng / ml 2 Greater than 0.9950, in line with the indicators.

[0141] 2. Detection limit

[0142] Using sample diluent (0.5% BSA-PBS) as the sample, repeat the measurement 24 times, obtain the OD450 value of the 24 measurement results, calculate the mean (M) and standard deviation (SD), obtain the A450 value corresponding to M+2SD, substitute it into the standard curve equation of the standard substance, and find the corresponding concentration value, which is the detection limit. The results are shown in Table 2, and the detection limit is 0.52ng / mL.

[0143] Table 2

[0144]

[0145]

[0146] 3. Limit of Quantitation

[0147] After the standard was diluted to 0.5, 1, and 1.5 ng / ml, the determination was repeated 10 times, and the average and SD of the 10 determination results were calculated to obtain the coefficient of variation (CV). The lowest concentration with CV ≤ 15% was selected as the limit of quantification. The results are shown in Table 3, and the limit of quantification was 1 ng / mL.

[0148] Table 3

[0149] Theoretical concentration (ng / mL) Detection concentration (ng / mL) SD CV 0.5 0.8 0.246 30.71% 1 1.12 0.144 12.89% 1.5 1.52 0.131 8.60%

[0150] 4. Specificity

[0151] The established method was used to detect a variety of dust mite allergens. Except for Der p 1, the OD 450 values ​​of different concentrations of Der p 2, Der f 1, and Der f 2 (purchased from Indoor Biotechnologies) were all lower than the blank, indicating that the double antibody sandwich Elisa kit prepared by the present invention can specifically detect Der p 1 and has no cross reaction to Der p 2, Der f 1, and Der f 2. The results are shown in Figure 2 shown.

[0152] 5. Accuracy

[0153] The Der p 1 antigen prepared in Example 1 was prepared into a standard solution (100, 10 ng / mL) and added to a low-value sample of known concentration at a volume ratio of 1:9. The test was repeated 3 times using the kit, and the recovery rate R was calculated according to the formula below. The results are shown in Table 4.

[0154]

[0155] Where:

[0156] R—Recovery rate

[0157] V—Volume of standard solution added

[0158] V0—low sample volume

[0159] C—Measured concentration of sample after spike

[0160] C0—low value sample concentration

[0161] C S —Concentration of standard solution

[0162] Table 4

[0163]

[0164] 6. Precision

[0165] Ten wells of each of the quality control products QC1, QC2 and QC3 were measured in parallel, and the CV was calculated. The results are shown in Table 5.

[0166] Table 5

[0167] M (ng / mL) SD CV QC1 2.24 0.13 5.80% QC2 7.75 0.23 2.97% QC3 20.07 1.79 8.92%

[0168] The results indicate that the antibodies prepared by the hybridoma cells DP1.10 and DF1.7 for preparing monoclonal antibodies against Der p 1, a major allergen of house dust mites, can obtain monoclonal antibodies against Der p 1 with good specificity. The antibodies have strong specificity and can be used as coated antibodies in ELISA to detect Der p 1 antigen.

[0169] Comparative Example

[0170] The Der p 1 detection kit (Indoor Biotechnologies) available on the market was used to detect Der p 1 by double antibody sandwich method, and the detection limit obtained was 0.78 ng / mL, and the total incubation time of the sample and the detection antibody was 2 hours.

[0171] This indicates that the reagent for detecting Der p 1 provided by the present invention has a high sensitivity.

Claims

1. A hybridoma cell for preparing a monoclonal antibody against Der p 1, a major allergen of house dust mites, characterized in that: The deposit numbers of the hybridoma cells are: CGMCC No.45843 and CGMCC No.45844.

2. An antibody pair for detecting the content of Der p 1, a major allergen of house dust mites, characterized in that: The method comprises injecting hybridoma cells CGMCC No.45843 and CGMCC No.45844 into parous BALB / c female mice intraperitoneally, collecting ascites, purifying monoclonal antibodies, and obtaining anti-Der p 1 monoclonal antibodies DP1.10 and DF1.

7.

3. Use of the antibody pair for detecting the content of house dust mite allergen Der p 1 according to claim 2 in the preparation of a preparation for detecting the main Der p 1 antigen of house dust mite.

4. A detection kit for detecting the major allergen Der p 1 of house dust mites, comprising a monoclonal antibody prepared by mouse hybridoma cells with a deposit number of CGMCC No. 45843 as a capture antibody, and a monoclonal antibody labeled with HRP prepared by mouse hybridoma cells with a deposit number of CGMCC No. 45844 as a detection antibody.

5. A method for detecting the main allergen Der p 1 of house dust mites, characterized in that: It includes the following steps: S1. The antibody prepared by hybridoma cell CGMCC No.45844 is used as capture antibody to coat the ELISA coated plate; S2, after washing, block with blocking solution and then wash; S3, adding the test solution to the ELISA coated plate, incubating, and washing; S4, adding HRP-conjugated antibodies prepared by hybridoma cell CGMCC No.45845, incubating, and then washing; S5. After adding TMB, the reaction was terminated by adding stop solution and the absorbance at a wavelength of 450 nm was detected by an ELISA reader.

6. The method according to claim 5, characterized in that At the same time, standard samples with different Der p 1 protein concentrations were prepared. After detection according to the above method, a dose-response standard curve was drawn. Then, the absorbance value of the test solution was substituted into the standard curve to obtain the concentration of Der p 1 protein in the test solution.

Citation Information

Cited By

  • Dermatophagoides pteronyssinus allergen component Der p 10 specific IgE calibrator and preparation method and application thereof

    CN122427276A

  • A specific IgE calibrator for the dust mite allergen component Der p 10, its preparation method, and its application.

    CN122427276B